Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04637009 |
Title | A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Astex Pharmaceuticals, Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Alabama - Birmingham Comprehensive Cancer Center | Birmingham | Alabama | 35233 | United States | Details | |
HonorHealth Research Institute | Scottsdale | Arizona | 82528 | United States | Details | |
University of Southern California Keck School of Medicine | Los Angeles | California | 90033 | United States | Details | |
Augusta University - Georgia Cancer Center | Augusta | Georgia | 30912 | United States | Details | |
Norton Cancer Institute | Louisville | Kentucky | 40241 | United States | Details | |
Weill Cornell Medicine and New York - Presbyterian Hospital | New York | New York | 10065 | United States | Details | |
Cleveland Clinic Taussig Cancer Institute | Cleveland | Ohio | 44195 | United States | Details | |
University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
University of Alberta Hospital - Hematology Research | Edmonton | Alberta | T6G 2V2 | Canada | Details | |
Princess Margaret Hospital | Toronto | Ontario | M5G 2L7 | Canada | Details |